Journal of Nuclear Medicine · 2010 · 35 citations · 16 references
MedicineNuclear MedicineToxicologyMolecular ImagingRadiobiologyRenal Nuclear MedicineRenal DiseaseRenal ImagingRenal Nuclear ImagingRenal ScintigraphyRenal ToxicityImpaired Kidney FunctionKidney DosimetryMechanisms Of Renal ToxicityRadiation Dose EffectsRadiation Dose EstimationRenal Function EvaluationRenal Nuclear ScintigraphyTc-99m Mercaptoacetyltriglycine Renal Scintigraphy
UNLABELLED: We determined the renal radiation dose of a series of (111)In-labeled peptides using animal SPECT. Because the animals' health deteriorated, renal toxicity was assessed. METHODS: Wild-type and megalin-deficient mice were imaged repeatedly at 3- to 6-wk intervals to quantify renal retention after injection of 40-50 MBq of (111)In-diethylenetriaminepentaacetic acid-labeled peptides (octreotide, exendin, octreotate, neurotensin, and minigastrin analogs), and the absorbed kidney radiation doses were estimated. Body weight, renal function parameters, and renal histology were determined at 16-20 wk after the first scan and compared with those in naive animals. RESULTS: Because of high renal retention, (111)In-diethylenetriaminepentaacetic acid-exendin-4 scans resulted in a 70-Gy kidney radiation dose in wild-type mice. Megalin-deficient kidneys received 20-40 Gy. The other peptides resulted in much lower renal doses. Kidney function monitoring indicated renal damage in imaged animals. CONCLUSION: Micro-SPECT enables longitudinal studies in 1 animal. However, long-term nephrotoxic effects may be induced after high renal radiation doses, even with (111)In-labeled radiotracers.
16
Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam et al. · Journal of Clinical Oncology · 2008 · 1.4K citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Yttrium-90 DOTATOC: first clinical results
Andreas Otte, R. Herrmann, A. Heppeler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1999 · 327 citations
Hypocalcemia and osteopathy in mice with kidney‐specific megalin gene defect
Jörg R. Leheste, F. Melsen, Maren Wellner et al. · The FASEB Journal · 2002 · 184 citations
Medicine, Endocrinology, Nephrology +17